Attached files
| file | filename |
|---|---|
| EX-10.14 - FORM OF RESTRICTED STOCK UNIT NOTICE AND RESTRICTED STOCK UNIT AGREEMENT BETWEEN - ORAMED PHARMACEUTICALS INC. | f10k2017ex10-14_oramed.htm |
| 10-K - ANNUAL REPORT - ORAMED PHARMACEUTICALS INC. | f10k2017_oramedpharma.htm |
| EX-32.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2017ex32-2_oramed.htm |
| EX-32.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2017ex32-1_oramed.htm |
| EX-31.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2017ex31-2_oramed.htm |
| EX-31.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC. | f10k2017ex31-1_oramed.htm |
| EX-10.23 - REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS - ORAMED PHARMACEUTICALS INC. | f10k2017ex10-23_oramed.htm |
| EX-10.11 - AMENDMENT, DATED JUNE 30, 2017, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED L - ORAMED PHARMACEUTICALS INC. | f10k2017ex10-11_oramed.htm |
| EX-3.1 - COMPOSITE COPY OF CERTIFICATE OF INCORPORATION, AS AMENDED AS OF JANUARY 22, 201 - ORAMED PHARMACEUTICALS INC. | f10k2017ex3-1_oramed.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-215525 and 333-190497) and Form S-8 (Nos. 333-213835, 333-199120, 333-190222 and 333-163919) of Oramed Pharmaceuticals Inc. of our report dated November 29, 2017 relating to the financial statements, which appears in this Form 10-K.
| Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
| November 29, 2017 | Certified Public Accountants (lsr.) |
| A member firm of PricewaterhouseCoopers International Limited |